SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001140361-23-039736
Filing Date
2023-08-14
Accepted
2023-08-14 17:26:20
Documents
4
Group Members
XYLOPHONE ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-C brhc20057481_formsctoc.htm SC TO-C 23557
2 EXHIBIT 99.1 brhc20057481_ex99-1.htm EX-99.1 27757
3 EXHIBIT 99.2 brhc20057481_ex99-2.htm EX-99.2 57084
4 image00001.jpg GRAPHIC 4861
  Complete submission text file 0001140361-23-039736.txt   116994
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88971 | Film No.: 231172164
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filed by) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations